Literature DB >> 17368581

EGFR phosphorylation-dependent formation of cell-cell contacts by Ras/Erks cascade inhibition.

Eun-Sil Kang1, Min-A Oh, Sin-Ae Lee, Tae Young Kim, Sung-Hoon Kim, Noriko Gotoh, Yong-Nyun Kim, Jung Weon Lee.   

Abstract

Cell-cell contacts play important roles in the homeostasis of normal epithelium and in the steps of metastasis of tumor cells, although signaling mechanisms to regulate cell-cell contacts are unclear. In this study, we observed that phenotype of no cell-cell contacts in rat intestinal epithelial cell subline (RIE1-Sca) correlated with increased Erk1/2 signaling activity, compared to that of parental RIE1 cells growing in colonies. Furthermore, cell-cell contacts between RIE1-Sca cells were reformed by treatment with a specific MEK inhibitor (U0126), with translocation of ZO1 and beta-catenin to cell-cell contacts, without changes of their expression levels. U0126 treatment also increased EGFR phosphorylation in a ligand-independent manner. Pretreatment with EGFR kinase inhibitor abolished U0126 treatment-mediated EGFR phosphorylation, and expression of dominant negative H-Ras N17 allowed EGFR phosphorylation and cell-cell contacts even without U0126 treatment. Furthermore, the expression of a nonphosphorylatable EGFR Y5F mutant abolished U0126-mediated cell-cell contacts. U0126 treatment also caused less efficient wound healing by keeping monolayer integrity intact, compared to control untreated cells. This U0126-mediated reduction in wound healing was further altered either by pretreatment of EGFR kinase inhibitor or expression of H-Ras N17 or EGFR Y5F. Taken together, this study supports a unique mechanism of cell-cell contact formation through MEK/Erks inhibition-mediated EGFR phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368581     DOI: 10.1016/j.bbamcr.2007.02.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro.

Authors:  Yang Shen; Mulan Ren; Yuehua Shi; Yunxia Zhang; Yunlang Cai
Journal:  Exp Ther Med       Date:  2011-08-11       Impact factor: 2.447

2.  Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.

Authors:  Sylwia Ammoun; Marei Caroline Schmid; Joceline Triner; Paul Manley; Clemens Oliver Hanemann
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

3.  ZC3H15 promotes glioblastoma progression through regulating EGFR stability.

Authors:  Jianbing Hou; Minghao Xu; Hongyu Gu; Dakun Pei; Yudong Liu; Pan Huang; Hongbo Chang; Hongjuan Cui
Journal:  Cell Death Dis       Date:  2022-01-13       Impact factor: 8.469

4.  Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.

Authors:  Heba Alshaker; Jonathan Krell; Adam E Frampton; Jonathan Waxman; Oleg Blyuss; Alexey Zaikin; Mathias Winkler; Justin Stebbing; Ernesto Yagüe; Dmitri Pchejetski
Journal:  Breast Cancer Res       Date:  2014-10-25       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.